Stepan Laboratories Private Limited, a active private limited company, was established on 01 June 1988 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1988PTC031908. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.73 M.
It upholds a compliant status. Its leadership includes Gaurav Agrawal (Director), Charu Agrawal (Additional Director), Shri Agrawal Krishan (Director). Past directors included Renu Bajaj, Gaurav Agrawal. It holds ₹1.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 20 Bhalaswa, New Delhi, Delhi.
U74899DL1988PTC031908
031908
01 June 1988
₹1.00 M
₹0.73 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Stepan Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Agrawal | Director | 24 May 2019 | Current |
| Charu Agrawal | Additional Director | 15 Apr 2019 | Current |
| Shri Agrawal Krishan | Director | 01 Jun 1988 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Mar 2007 | Past |
| Pramod Abcsdd | Director | 15 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stepan Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.71% decrease. The company also saw a substantial fall in profitability, with a 73.87% decrease in profit. The company's net worth moved up by a moderate rise of 1.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Stepan Laboratories had a public holding of 12.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Apr 2019 | Axis Bank Limited | ₹1.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Stepan Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stepan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stepan Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Stepan Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Stepan Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Gaurav Agrawal was appointed as a Director was appointed as a Director on 24 May 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 1.50 M with Charge ID 100282413 was registered on 22 Apr 2019. was completed.
Charu Agrawal was appointed as a Additional Director was appointed as a Additional Director on 15 Apr 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Progress on Shri Agrawal Krishan was appointed as a Director was appointed as a Director on 01 Jun 1988 & has been associated with this company since 37 years 7 months . was documented.
The CIN of Stepan Laboratories Private Limited is U74899DL1988PTC031908.
Stepan Laboratories Private Limited is headquartered at 20 Bhalaswa, New Delhi, Delhi.
Stepan Laboratories Private Limited was incorporated on 01 June 1988.
The current directors of Stepan Laboratories Private Limited are
The primary industry of Stepan Laboratories Private Limited is Manufacturing.
Stepan Laboratories Private Limited is unlisted.
The authorized capital of Stepan Laboratories Private Limited is ₹1.00 M, and the paid-up capital is ₹0.73 M.
The compliance status of Stepan Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX